Towards an HIV Cure Symposium July 2012: Call for Abstracts
February 2012 - Under the auspices of the International AIDS Society, an international working group
of researchers is developing a Global Scientific Strategy Towards an HIV Cure. The strategy aims at building a global
consensus defining scientific priorities for HIV cure research.
Track A and B (basic and clinical sciences) abstracts submitted to the International AIDS Conference and
related to the topic of HIV cure can be considered for the symposium (oral presentations and posters), while a summary
of the results from the symposium will be shared with the expected 25 to 30 thousand participants attending AIDS
2012. We encourage abstracts to be submitted in the track categories outlined below, from the basic science section:
A27: Viral Mechanisms of Persistence and Latency
A28: Mechanisms of Eradication
A29: Tissue Reservoirs
A30: Host Cellular Factors and Latency
Abstract submission will close at midnight CET on 15 February 2012. Please submit abstracts online
at: http://www.aids2012.org/. Late breakers will also be
considered (submission between 19 April and 22 May on www.aids2012.org). Selected
abstract presenters will be awarded scholarships for both the workshop and AIDS 2012. Applications for these awards can be made
online at http://www.aids2012.org/ from 8 December 2011 through 15
February 2012. The best abstract presented by a young investigator will receive the IAS-ANRS Prize on HIV Cure, to be
awarded at the symposium.
There will be seven sessions held at the symposium; the preliminary titles for each session are as follows:
Cellular and viral mechanisms that maintain HIV persistence.
Tissue and cellular sources of persistent HIV in long-term ART-treated individuals.
Origins of immune activation and inflammation in the presence of ART and their consequences for HIV persistence.
Host and immune mechanisms that control infection but allow viral persistence.
Assays to measure persistent infection: Comparison and validation.
Therapeutic agents or immunological strategies to safely eliminate latent infection in individuals on ART.
Strategies to enhance the capacity of the host response to control active viral replication.
Please click here for more detailed
information on the background and objectives of this initiative and for any additional information please contact
The Symposium Programme Committee:
Alain Lafeuillade, France
Alan Landay, USA
Ann Woolfrey, USA
Carine van Lint, Belgium
David Margolis, USA
Françoise Barré-Sinoussi, France
Jim Mullins, USA
Mark Harrington, USA
Melissa Churchill, Australia
Paula Munderi, Uganda
Rowena Johnston, USA
Sarah Palmer, Sweden
Sharon Lewin, Australia
Steven Deeks, USA